# Medicinova Inc: filings

MNOV · Nasdaq · CIK 1226616 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnov.md) · [Financials](/companies/mnov/financials.md) · [Filings](/companies/mnov/filings.md) · [Insiders](/companies/mnov/insiders.md)

## Reports and events: 299 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 200, 4 185, 10-Q 53, 3 25, 10-K 18, DEF 14A 18, SC 13G/A 16, 424B5 14, EFFECT 11, 425 10, ARS 10, DEFA14A 10, CORRESP 9, S-3 9, UPLOAD 9, SC 13G 8, 4/A 6, S-8 4, S-8 POS 4, SC 13D/A 4, 424B3 3, S-3/A 3, S-4/A 3, SC 13D 3, CT ORDER 2, PRE 14A 2, 10-K/A 1, 8-A12G/A 1, PRER14A 1, S-1 1, S-4 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001213900-26-104738.md) | Ownership report, active investor, amended | 0001213900-26-104738 |
| 2026-09-28 | 16:05 ET | [8-K](/filings/0001193125-26-405318.md) | 1.01 Entry into a material agreement | 0001193125-26-405318 |
| 2026-09-02 | 07:30 ET | [8-K](/filings/0001193125-26-379348.md) | 1.02 Termination of a material agreement | 0001193125-26-379348 |
| 2026-08-19 | 07:30 ET | [8-K](/filings/0001193125-26-356146.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-356146 |
| 2026-08-13 | 16:30 ET | [10-Q](/filings/0001193125-26-349323.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349323 |
| 2026-06-24 | 16:38 ET | [8-K](/filings/0001193125-26-281171.md) | 5.07 Shareholder vote results | 0001193125-26-281171 |
| 2026-05-14 | 16:15 ET | [10-Q](/filings/0001193125-26-224066.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224066 |
| 2026-04-29 | 16:26 ET | [DEF 14A](/filings/0001193125-26-191866.md) | Proxy statement, period 2026-06-23 | 0001193125-26-191866 |
| 2026-03-10 | 17:15 ET | [10-K](/filings/0001193125-26-100432.md) | Annual report, period 2025-12-31 | 0001193125-26-100432 |
| 2026-02-20 | 06:25 ET | [8-K](/filings/0001193125-26-060232.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-060232 |
| 2025-12-30 | 07:53 ET | [8-K](/filings/0001193125-25-335917.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-335917 |
| 2025-11-12 | 16:35 ET | [10-Q](/filings/0001193125-25-277779.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277779 |
| 2025-08-22 | 16:22 ET | [S-1](/filings/0001193125-25-186446.md) | Registration statement | 0001193125-25-186446 |
| 2025-08-14 | 17:02 ET | [10-Q](/filings/0000950170-25-109041.md) | Quarterly report, period 2025-06-30 | 0000950170-25-109041 |
| 2025-08-01 | 19:49 ET | [8-K](/filings/0001193125-25-170744.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-170744 |
| 2025-06-18 | 16:30 ET | [8-K](/filings/0000950170-25-087924.md) | 5.07 Shareholder vote results | 0000950170-25-087924 |
| 2025-05-13 | 16:39 ET | [10-Q](/filings/0000950170-25-070461.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070461 |
| 2025-04-28 | 16:15 ET | [DEF 14A](/filings/0000950170-25-059321.md) | Proxy statement, period 2025-06-17 | 0000950170-25-059321 |
| 2025-03-11 | 16:45 ET | [8-K](/filings/0001193125-25-051990.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-051990 |
| 2025-02-19 | 16:55 ET | [10-K](/filings/0000950170-25-023301.md) | Annual report, period 2024-12-31 | 0000950170-25-023301 |
| 2024-11-13 | 16:17 ET | [10-Q](/filings/0000950170-24-126343.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126343 |
| 2024-08-08 | 16:32 ET | [10-Q](/filings/0000950170-24-094092.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094092 |
| 2024-06-12 | 16:15 ET | [8-K](/filings/0000950170-24-072461.md) | 5.07 Shareholder vote results | 0000950170-24-072461 |
| 2024-05-09 | 16:15 ET | [10-Q](/filings/0000950170-24-056996.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056996 |
| 2024-04-26 | 16:15 ET | [DEF 14A](/filings/0000950170-24-049146.md) | Proxy statement, period 2024-06-11 | 0000950170-24-049146 |
| 2024-04-01 | 16:06 ET | [8-K](/filings/0001193125-24-083356.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-083356 |
| 2024-02-15 | 16:25 ET | [10-K](/filings/0000950170-24-015920.md) | Annual report, period 2023-12-31 | 0000950170-24-015920 |
| 2023-11-09 | 16:15 ET | [10-Q](/filings/0000950170-23-062079.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062079 |
| 2023-08-09 | 16:17 ET | [10-Q](/filings/0000950170-23-040621.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040621 |
| 2023-08-07 | 16:05 ET | [8-K](/filings/0001193125-23-204956.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-204956 |
| 2023-06-22 | 16:30 ET | [8-K](/filings/0001193125-23-172585.md) | 3.01 Delisting notice | 0001193125-23-172585 |
| 2023-06-14 | 20:02 ET | [8-K](/filings/0000950170-23-027823.md) | 5.07 Shareholder vote results | 0000950170-23-027823 |
| 2023-05-11 | 16:19 ET | [10-Q](/filings/0000950170-23-021279.md) | Quarterly report, period 2023-03-31 | 0000950170-23-021279 |
| 2023-04-26 | 16:26 ET | [8-K](/filings/0001193125-23-118572.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-118572 |
| 2023-04-26 | 16:15 ET | [DEF 14A](/filings/0000950170-23-014814.md) | Proxy statement, period 2023-06-13 | 0000950170-23-014814 |
| 2023-03-28 | 16:16 ET | [10-K/A](/filings/0000950170-23-010297.md) | Annual report, amended, period 2022-12-31 | 0000950170-23-010297 |
| 2023-02-16 | 16:15 ET | [10-K](/filings/0000950170-23-003054.md) | Annual report, period 2022-12-31 | 0000950170-23-003054 |
| 2022-11-10 | 16:19 ET | [10-Q](/filings/0001564590-22-037391.md) | Quarterly report, period 2022-09-30 | 0001564590-22-037391 |
| 2022-08-11 | 16:16 ET | [10-Q](/filings/0001564590-22-029126.md) | Quarterly report, period 2022-06-30 | 0001564590-22-029126 |
| 2022-07-12 | 12:12 ET | [SC 13D/A](/filings/0001213900-22-038767.md) | Ownership report, active investor, amended | 0001213900-22-038767 |
| 2022-06-21 | 16:06 ET | [8-K](/filings/0001193125-22-177628.md) | 5.02 Departure or appointment of officers or directors | 0001193125-22-177628 |
| 2022-06-15 | 17:16 ET | [8-K](/filings/0001564590-22-023341.md) | 5.07 Shareholder vote results | 0001564590-22-023341 |
| 2022-05-12 | 16:17 ET | [10-Q](/filings/0001564590-22-019872.md) | Quarterly report, period 2022-03-31 | 0001564590-22-019872 |
| 2022-04-26 | 16:15 ET | [DEF 14A](/filings/0001564590-22-015688.md) | Proxy statement, period 2022-06-14 | 0001564590-22-015688 |
| 2022-04-05 | 18:01 ET | [8-K](/filings/0001193125-22-095275.md) | 8.01 Other events | 0001193125-22-095275 |
| 2022-02-16 | 16:26 ET | [10-K](/filings/0001564590-22-005388.md) | Annual report, period 2021-12-31 | 0001564590-22-005388 |
| 2021-11-12 | 06:03 ET | [10-Q](/filings/0001564590-21-056378.md) | Quarterly report, period 2021-09-30 | 0001564590-21-056378 |
| 2021-08-12 | 16:16 ET | [10-Q](/filings/0001564590-21-043988.md) | Quarterly report, period 2021-06-30 | 0001564590-21-043988 |
| 2021-08-02 | 16:21 ET | [8-K](/filings/0001193125-21-233293.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-233293 |
| 2021-07-23 | 16:02 ET | [8-K](/filings/0001193125-21-222985.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-21-222985 |

Page 1 of 6. [Older](/companies/mnov/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:11 ET. No prices; not investment advice.